Mary Chamberlin
Dartmouth-Hitchcock Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mary Chamberlin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:57 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05933395 · Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 InhibitorDartmouth-Hitchcock Medical Center · recruiting · Advanced Breast Cancer · principal investigator
- Ph1NCT05900895 · Estradiol Plus Olaparib for Breast Cancer (PHOEBE)Mary D Chamberlin · recruiting · Metastatic Breast Cancer · principal investigator
- Ph2NCT02188745 · ER Reactivation Therapy for Breast CancerDartmouth-Hitchcock Medical Center · completed · Metastatic Breast Cancer · principal investigator
- N/ANCT02159157 · A Randomized, Controlled Trial to Determine the Effects of an Exercise Intervention on Physical Activity During Chemotherapy for Patients With Early Stage Breast CancerDartmouth-Hitchcock Medical Center · completed · Early Stage Breast Cancer · principal investigator
- N/ANCT01653366 · Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic PathwayDartmouth-Hitchcock Medical Center · terminated · Metastatic Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:57 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- 121 citationsRCR 7.8
- Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.Cancer Res · 202527 citationsRCR 5.6
- 14 citationsRCR 3.4
- Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 Pandemic.JCO Oncol Pract · 20238 citationsRCR 1.1
- Health Through Activity: Initial Evaluation of an In-Home Intervention for Older Adults With Cancer.Am J Occup Ther · 20197 citationsRCR 0.3
- Telephone-Based Rehabilitation Intervention to Optimize Activity Participation After Breast Cancer: A Randomized Clinical Trial.JAMA Netw Open · 20246 citationsRCR 2.1
- Exercise That Feels as Good as Possible: Acceptability of an Affect-Based Exercise Prescription Among Stage 0-III Breast Cancer Survivors.Psychooncology · 20251 citationsRCR 0.6